Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF）
Clinical trial NCT05119972 · COMPLETED
Trial details
- NCT number
- NCT05119972
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2023-12-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.